We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+6.21%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$112B
AUM Growth
+$9.17B
Cap. Flow
+$3.28B
Cap. Flow %
2.93%
Top 10 Hldgs %
16.06%
Holding
4,415
New
305
Increased
1,505
Reduced
1,905
Closed
456

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$424M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$333M
3
XIV
VelocityShares Daily Inverse VIX Short Term ETN
XIV
+$271M
4
MRK icon
Merck
MRK
+$234M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$231M

Top Sells

Rank Stock Value
1
EWY icon
iShares MSCI South Korea ETF
EWY
+$280M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$232M
3
CHTR icon
Charter Communications
CHTR
+$214M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$212M
5
BABA icon
Alibaba
BABA
+$189M

Sector Composition

Rank Sector Weight
1 Technology 11.36%
2 Financials 11.09%
3 Healthcare 9.9%
4 Consumer Discretionary 6.79%
5 Industrials 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACGN
3726
DELISTED
Aceragen Inc
ACGN
$86K ﹤0.01%
299
-235
-44% -$67.1K
CPRX
3727
DELISTED
Catalyst Pharmaceutical
CPRX
$84K ﹤0.01%
21,627
-26,077
-55% -$86.2K
AUY
3728
PUT
DELISTED
Yamana Gold, Inc.
AUY
$84K ﹤0.01%
26,800
– –
MR
3729
DELISTED
Montage Resources Corporation Common Stock
MR
$84K ﹤0.01%
2,336
-2,376
-50% -$85.8K
TNK icon
3730
Teekay Tankers
TNK
$2.66B
$83K ﹤0.01%
7,381
-2,536
-26% -$31.2K
CMRX
3731
DELISTED
Chimerix, Inc.
CMRX
$83K ﹤0.01%
17,880
-49,245
-73% -$234K
SRGA
3732
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$83K ﹤0.01%
670
-662
-50% -$90.9K
ARDX icon
3733
Ardelyx
ARDX
$1.25B
$82K ﹤0.01%
12,412
-24,018
-66% -$142K
ATRS
3734
DELISTED
Antares Pharma, Inc.
ATRS
$82K ﹤0.01%
41,433
-52,608
-56% -$114K
AVID
3735
DELISTED
Avid Technology Inc
AVID
$81K ﹤0.01%
15,049
-14,891
-50% -$80.1K
MOBL
3736
DELISTED
MobileIron, Inc.
MOBL
$81K ﹤0.01%
20,932
-20,940
-50% -$80.9K
IMUX icon
3737
Immunic
IMUX
$182M
$80K ﹤0.01%
+34
New +$75.2K
ZIXI
3738
DELISTED
Zix Corporation
ZIXI
$80K ﹤0.01%
18,354
-19,211
-51% -$90.4K
NERV icon
3739
Minerva Neurosciences
NERV
$199M
$79K ﹤0.01%
1,631
-1,453
-47% -$72K
SRL icon
3740
Scully Royalty
SRL
$76.7M
$78K ﹤0.01%
10,000
– –
CALX icon
3741
Calix
CALX
$2.34B
$77K ﹤0.01%
12,964
-42,631
-77% -$258K
CCEC
3742
Capital Clean Energy Carriers
CCEC
$1.36B
$77K ﹤0.01%
3,262
-240
-7% -$5.64K
PVLA
3743
Palvella Therapeutics
PVLA
$2.05B
$77K ﹤0.01%
127
-162
-56% -$75.3K
LAB icon
3744
Standard BioTools
LAB
$311M
$76K ﹤0.01%
13,024
-7,027
-35% -$38.5K
SIGM
3745
DELISTED
Sigma Designs Inc
SIGM
$76K ﹤0.01%
10,891
-13,813
-56% -$86.6K
MCHX icon
3746
Marchex
MCHX
$79.3M
$75K ﹤0.01%
+23,078
New +$73.8K
BCOV
3747
DELISTED
Brightcove, Inc.
BCOV
$74K ﹤0.01%
10,466
-17,668
-63% -$128K
BW icon
3748
Babcock & Wilcox
BW
$1.31B
$73K ﹤0.01%
1,298
-5,470
-81% -$248K
KOPN icon
3749
Kopin
KOPN
$654M
$73K ﹤0.01%
22,809
-18,088
-44% -$62.3K
LCTX icon
3750
Lineage Cell Therapeutics
LCTX
$267M
$73K ﹤0.01%
39,001
-26,246
-40% -$57.3K
148 149
150
151 152

Similar funds

CSIA
Charles Schwab Investment Advisory San Francisco, California $72.8B AUM 10.03% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
MNG
Manning & Napier Group Fairport, New York $8.76B AUM 23.27% 1-Year Est. Return
DPAM
Degroof Petercam Asset Management Brussels, Belgium $8.32B AUM
ICG
InterOcean Capital Group Nashville, Tennessee $4.19B AUM 26.29% 1-Year Est. Return
CW
Connectus Wealth Cincinnati, Ohio $3.66B AUM 26.47% 1-Year Est. Return

Credit Suisse's Q4 2017 Portfolio in Review

As of Q4 2017, Credit Suisse held 4,415 positions worth $112B, up 8.9% from $103B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Credit Suisse's Q4 2017 filing shows 305 new, 1,505 increased, 1,905 reduced and 456 closed positions. Its largest new stake was Vanguard FTSE Pacific ETF: 1,427,144 shares worth $104M. The largest sale was iShares MSCI South Korea ETF, an estimated $280M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Credit Suisse's largest Q4 2017 buy was Vanguard FTSE Pacific ETF: 1,427,144 shares worth $104M.
  • Credit Suisse added most to Citigroup in Q4 2017, an estimated $424M increase.
  • Credit Suisse's biggest Q4 2017 reduction was iShares MSCI South Korea ETF, cutting an estimated $280M.
  • Credit Suisse fully exited Fortress Investment Group Llc in Q4 2017, selling an estimated $86.9M.
  • Credit Suisse's ten largest holdings make up 16% of its $112B portfolio in Q4 2017.
  • Credit Suisse opened 305 new positions and closed 456 in Q4 2017.
  • Credit Suisse's portfolio value rose 8.9% quarter-over-quarter to $112B.

Based on Credit Suisse's 13F filing for Q4 2017, filed 14 Feb 2018.